Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10515987rdf:typepubmed:Citationlld:pubmed
pubmed-article:10515987lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C1512035lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0038590lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0596233lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C1152715lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C0521116lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:10515987lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:10515987pubmed:issue4lld:pubmed
pubmed-article:10515987pubmed:dateCreated1999-11-5lld:pubmed
pubmed-article:10515987pubmed:abstractTextMetabotropic glutamate receptors modulate neuronal excitability via a multitude of mechanisms, and they have been implicated in the pathogenesis of neurodegenerative processes. Here we investigated the responses mediated by group I metabotropic glutamate receptors (mGluRs) in dopamine neurons of the rat substantia nigra pars compacta, using whole cell patch-clamp recordings in combination with microfluorometric measurements of [Ca(2+)](i) and [Na(+)](i). The selective group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (3,5-DHPG) was bath-applied (20 microM, 30 s to 2 min) or applied locally by means of short-lasting (2-4 s) pressure pulses, delivered through an agonist-containing pipette positioned close to the cell body of the neuron. 3,5-DHPG evoked an inward current characterized by a transient and a sustained component, the latter of which was uncovered only with long-lasting agonist applications. The fast component coincided with a transient elevation of [Ca(2+)](i), whereas the total current was associated with a rise in [Na(+)](i). These responses were not affected either by the superfusion of ionotropic excitatory amino acid antagonists 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and D-2-amino-5-phosphono-pentanoic acid (D-APV), nor by the sodium channel blocker tetrodotoxin (TTX). (S)-alpha-methyl-4-carboxyphenylglycine (S-MCPG) and the more selective mGluR1 antagonist 7(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate (CPCCOEt) depressed both 3,5-DHPG-induced inward current components and, although less effectively, the associated [Ca(2+)](i) elevations. On repeated agonist applications the inward current and the calcium transients both desensitized. The time constant of recovery from desensitization differed significantly between these two responses, being 67.4+/-4.4 s for the inward current and 28.6+/-2.7 s for the calcium response. Bathing the tissue in a calcium-free/EGTA medium or adding thapsigargin (1 microM) to the extracellular medium prevented the generation of the [Ca(2+)](i) transient, but did not prevent the activation of the inward current. These electrophysiological and fluorometric results show that the 3, 5-DHPG-induced inward current and the [Ca(2+)](i) elevations are mediated by independent pathways downstream the activation of mGluR1.lld:pubmed
pubmed-article:10515987pubmed:languageenglld:pubmed
pubmed-article:10515987pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:citationSubsetIMlld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10515987pubmed:statusMEDLINElld:pubmed
pubmed-article:10515987pubmed:monthOctlld:pubmed
pubmed-article:10515987pubmed:issn0022-3077lld:pubmed
pubmed-article:10515987pubmed:authorpubmed-author:BernardiGGlld:pubmed
pubmed-article:10515987pubmed:authorpubmed-author:MercuriN BNBlld:pubmed
pubmed-article:10515987pubmed:authorpubmed-author:KnöpfelTTlld:pubmed
pubmed-article:10515987pubmed:authorpubmed-author:GuatteoEElld:pubmed
pubmed-article:10515987pubmed:issnTypePrintlld:pubmed
pubmed-article:10515987pubmed:volume82lld:pubmed
pubmed-article:10515987pubmed:ownerNLMlld:pubmed
pubmed-article:10515987pubmed:authorsCompleteYlld:pubmed
pubmed-article:10515987pubmed:pagination1974-81lld:pubmed
pubmed-article:10515987pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:meshHeadingpubmed-meshheading:10515987...lld:pubmed
pubmed-article:10515987pubmed:year1999lld:pubmed
pubmed-article:10515987pubmed:articleTitleGroup I metabotropic glutamate receptors mediate an inward current in rat substantia nigra dopamine neurons that is independent from calcium mobilization.lld:pubmed
pubmed-article:10515987pubmed:affiliationIRCCS S. Lucia, Università di Tor Vergata, 00179 Rome, Italy.lld:pubmed
pubmed-article:10515987pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10515987pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10515987lld:pubmed